Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

In a recent conversation with Managed Healthcare Executive, Hunter shared reflections on his tenure, the challenges of ...

A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain ...

This number can be attributed to claim denials, high deductibles and the underutilization of digital tools available within ...

Scientists working at the NIH’s BRAIN Initiative have created new viral vectors that one day could lead to gene therapies for ...

Almost half (48%) of HIV patients sometimes feel unheard by their healthcare providers, which highlights a need for increased ...

Pharmacy costs and outpatient facility care generate 69% of the cost increase for 2025, according to Milliman’s recent Medical Index.

Patients diagnosed with acquired (autoimmune) hemophilia, a serious and rare bleeding disorder, have high rates of hospital ...

Jason R. Smith, Pharm.D., appointed as chief pharmacy officer in February 2025 for the University of Rochester Medical Center ...

A case analysis provides a new understanding of the ocular side effects of Blenrep, an antibody drug conjugate that is being ...

A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...